Latest Medivir News & Updates

See the latest news and media coverage for Medivir. We track all announcements, press releases, and industry mentions in real time, all in one place.

Medivir

Oncology drug discovery and development company

medivir.com

Headquarters: Huddinge, Sweden
Founded year: 1988
Company type: Public company
Number of employees: 2–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Medivir

In short: Medivir raised capital through share issues, advanced clinical trials for fostrox and MIV-711, and secured new patents for liver cancer.

Company announcements

August 27 Medivir

Medivir hosts a webcast for its January-March 2027 interim report

The presentation occurs on April 29, 2027, discussing the company's financial performance for the first quarter of that year.

August 6 Medivir

Medivir hosts webcast for January-June 2026 interim report

The webcast takes place on August 20, 2026, covering the company's financial results for the period.

July 20 Medivir

Medivir's EGM approves directed share issue

The resolution was part of a two-tranche process initiated in June 2026. Up to 6,097,560 new shares to Hallberg Management AB were approved.

July 20 Medivir

Medivir receives Notice of Allowance for combination patent in USA

The patent covers fostrox plus lenvatinib for liver cancer treatment. It provides exclusivity until 2041.

Media coverage

August 21 Dagens PS

Lovable-duo sold a fraction and received 100 million each - Dagens PS

Much-discussed Medivir now tops all winner lists after a rocketing surge of over 300 percent on the stock exchange after Carl Bennet entered via a directed new issue...

August 20 Dagens industri

Continued negative figures for Medivir

The research company Medivir reports an EBITDA result for the second quarter of 2026 at minus 21.2 million SEK (minus 22.5).

August 20 Yahoo Finance

Medivir AB (STU:MVR0) (Q2 2026) Earnings Call Highlights: Advancing Fostrox in...

Medivir AB (STU:MVR0) reports strong progress across its pipeline, with key data readouts expected in 2027 and a strengthened cash position to fund operations into...

August 1 The Globe and Mail

Medivir Expands Share Capital to Fund MIV-711 Orphan Indication

Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities...

Never miss news about Medivir

Track Medivir and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Medivir competitors & trending companies

Browse news for competitors to Medivir and other trending companies.